These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6687443)
1. Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Levin VA; Vestnys PS; Edwards MS; Wara WM; Fulton D; Barger G; Seager M; Wilson CB Cancer; 1983 Apr; 51(8):1364-70. PubMed ID: 6687443 [TBL] [Abstract][Full Text] [Related]
2. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688 [TBL] [Abstract][Full Text] [Related]
4. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566 [TBL] [Abstract][Full Text] [Related]
5. Multimodality therapy for medulloblastoma. Thomas PR; Duffner PK; Cohen ME; Sinks LF; Tebbi C; Freeman AI Cancer; 1980 Feb; 45(4):666-9. PubMed ID: 6766791 [TBL] [Abstract][Full Text] [Related]
6. Response of medulloblastoma to vincristine sulfate: a case report. Lampkin BC; Mauer AM; McBride BH Pediatrics; 1967 May; 39(5):761-3. PubMed ID: 6026877 [No Abstract] [Full Text] [Related]
8. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study. van Eys J; Chen T; Moore T; Cheek W; Sexauer C; Starling K Cancer Treat Rep; 1981; 65(7-8):681-4. PubMed ID: 7248985 [TBL] [Abstract][Full Text] [Related]
10. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615 [TBL] [Abstract][Full Text] [Related]
11. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy. Rutkauskiene G; Labanauskas L Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in recurrent medulloblastoma. Duffner PK; Cohen ME; Thomas PR; Sinks LF; Freeman AI Cancer; 1979 Jan; 43(1):41-5. PubMed ID: 761175 [TBL] [Abstract][Full Text] [Related]
13. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies. Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654 [TBL] [Abstract][Full Text] [Related]
14. The change in patterns of relapse in medulloblastoma. Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192 [TBL] [Abstract][Full Text] [Related]
16. Rational approaches to the chemotherapy of medulloblastoma. Friedman HS; Schold SC Neurol Clin; 1985 Nov; 3(4):843-53. PubMed ID: 3908899 [TBL] [Abstract][Full Text] [Related]
17. [High-dose chemotherapy in relapse of medulloblastoma in young children]. Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
19. Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases. Seiler RW; Reichenbach W; Fricker U; Wagner HP Helv Paediatr Acta; 1978 Jun; 33(2):177-81. PubMed ID: 659260 [TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors]. Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]